Clinical trial

Blood-based Biomarkers for Diagnosis of Alzheimer's

NCT05187819

Study summary

ClinicalTrials.gov

Blood-based Biomarkers for Diagnosis of Alzheimer's

Design: INTERVENTIONAL · Status: RECRUITING · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DIAGNOSTIC_TEST · Unmapped registry intervention predictive value of a blood test Find medicine records · Find other trials using this name

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2023-06-01

PhaseNA

Conditions

Dementia Alzheimersunresolved

Interventions

predictive value of a blood testDIAGNOSTIC_TEST

Sponsors & collaborators

Helse Stavanger HFlead sponsor

Sahlgrenska University Hospitalcollaborator

Mapped research locations

StavangerNorway1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05187819 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.